Navigation Links
Bio-Optronics Adds Innovative Electronic Data Capture (EDC) Solution to Clinical Conductor Clinical Trial Management System (CTMS), Continues to Improve Workflow and Productivity
Date:4/14/2009

ROCHESTER, N.Y., April 14 /PRNewswire/ -- Bio-Optronics, Inc. and flexcipio s.a. are pleased to announce an agreement to cross-market and integrate Bio-Optronics' Clinical Conductor Clinical Trial Management System (CTMS) and flexcipio's eClinical Electronic Data Capture (EDC) solution. This aligns the industry's most comprehensive enterprise CTMS, with an innovative EDC, to provide clinical research with the best tools to optimize efficiency, productivity, and improve collaboration across the clinical environment. Clinical Conductor CTMS provides natural points in clinical trial workflow into which best-in-class tools and expertise can be integrated seamlessly.

Dan Kerpelman, Bio-Optronics President and CEO states, "Our extensive workflow expertise is a perfect match to flexcipio's data capture expertise." Pierre Ghyssens, flexcipio General Manager adds "Both our companies are dedicated to developing the latest solutions. By combining forces, we are able to provide a unique, global offering to the health sector."

Clinical Conductor CTMS, proven to improve site efficiency and productivity, handles the complete enterprise workflow, from business development, to patient databases, recruitment, scheduling, workload planning, finances, and complete oversight and reporting. The academic medical center CTMS solution adds research administration capabilities and custom interfaces to hospital enterprise systems.

eClinical EDC delivers powerful functionality and flexibility through a rich, interactive, user-friendly web-browser interface. EDC features include database definition, form design, QA process set-up, and powerful reporting. And, users are empowered to adapt the electronic data capture environment, intuitively. Qualified to the highest quality standards, data integrity and security are ensured, along with CDISC compliance.

Bio-Optronics, Inc. develops, deploys, and operates software products and custom information technology solutions to help healthcare professionals manage and optimize workflow, thus enhancing quality, productivity, and patient and staff satisfaction. For over 20 years, Bio-Optronics has demonstrated leadership in innovation, expertise in workflow and integration, and a singular approach to unparalleled customer service. Our workflow solutions are used in over 30 Veterans' Administration and other hospitals in the U.S., and over 400 clinical research sites around the world. www.bio-optronics.com

Flexcipio s.a., founded with a team of IT professionals and business specialists, focuses on applying the team's collective industries knowledge, experience, and professional network in a way that accelerates the design and the commercialization of innovative services, products, ideas, and technologies related to data capture. Flexcipio provides integrated web-based solutions that address industry needs for capturing and managing data in ensuring quality, security, and confidentially of collected information. www.flexcipio.com

Bio-Optronics, (877) 279-8377, www.bio-optronics.com; Maria Durkin, VP, Director Marketing and Operations, mdurkin@bio-optronics.com


'/>"/>
SOURCE Bio-Optronics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Former GE, Kodak and SGS Executive Dan Kerpelman to Join Bio-Optronics as President and CEO
2. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
3. Innovative Neurotronics, a Subsidiary of Hanger Orthopedic Group, Earns the 2007 da Vinci Award for the WalkAide System
4. CardioDynamics Receives FDA 510(k) Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
7. Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia
8. Innovative Fosshield(R) Antimicrobial Technology Shown to Continuously Kill MRSA Superbug
9. Ferndale and Foamix Enter Development of an Innovative Foam for the Treatment of Atopic Dermatitis
10. A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer
11. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Sequenom, Inc. (NASDAQ: ... enabling healthier lives through the development of innovative products ... the United States denied its ... the claims of Sequenom,s U.S. Patent No. 6,258,540 (",540 ... criteria established by the Supreme Court,s Mayo Collaborative Services ...
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... ... 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona ... or pleural mesothelioma. Their findings are the subject of a new article on the ... are signposts in the blood, lung fluid or tissue of mesothelioma patients that can ...
(Date:6/23/2016)... Md. , June 23, 2016 A person ... from the crime scene to track the criminal down. ... the U.S. Food and Drug Administration (FDA) uses DNA evidence ... Sound far-fetched? It,s not. The FDA ... sequencing to support investigations of foodborne illnesses. Put as simply ...
Breaking Biology Technology:
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
Breaking Biology News(10 mins):